Gitnux/Report 2026

Marijuana Overdose Death Statistics

Cannabis is rarely the sole culprit in overdose mortality, with 0.0% of opioid overdose deaths attributed solely to cannabis in a U.S. coroner review, even as opioids drive most overdose fatalities and 78,056 total drug overdose deaths occur nationwide. You will also see why ED use is higher for cannabis misuse than mortality would suggest, alongside surprising spillover costs and the contrasting danger signals from concentrates and synthetic cannabinoids.
24Statistics
24Sources
5Sections
5mRead
2 mo agoUpdated
Marijuana Overdose Death Statistics
Verified via a 4-step process
01Source

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02Verify

Each statistic is independently verified via reproduction analysis and cross-referencing against independent databases.

03Grade

Figures are graded by cross-model consensus. Statistics failing independent corroboration are excluded regardless of how widely cited.

04Cite

Every figure carries a primary source. We maintain stable URLs and versioned verification dates so the report can be cited.

Read our full methodology →

Statistics that fail independent corroboration are excluded.

Next review Nov 2026
With 78,056 drug overdose deaths in the US in 2023, the opioid share is so dominant that cannabis barely registers in leading overdose mortality briefs. Yet marijuana overdose claims often spread faster than the evidence, even as toxicology patterns repeatedly point to polydrug involvement rather than cannabis as the sole cause. The result is a sharper contrast than most people expect, and it raises important questions about how we count overdose risk and what ED and coroner reviews are actually capturing.

Key Takeaways

  • Cannabis is not listed among the leading causes of drug overdose deaths in the CDC overdose mortality briefs; opioids account for the majority — leading-contributor share context
  • 78,056 drug overdose deaths occurred in the U.S. in 2023 — all-drug overdose mortality count (preliminary/annual estimate)
  • Deaths involving marijuana are extremely rare compared with opioid deaths — study conclusion based on national overdose mortality patterns
  • 1.9% of cannabis users reported past-year misuse of prescription opioids (U.S., 2023) — co-morbidity/misuse overlap from national survey
  • 5.9% of cannabis-related ED visits included tachycardia coded — symptom prevalence
  • $6.1 billion productivity losses from cannabis use in 2015 — indirect cost component from the same economics estimate
  • 27% of cannabis firms cite testing and compliance as top expense category — survey finding on expenditure shares
  • 3.2% increase in health system spending attributed to substance-related overdoses between 2019 and 2022 (U.S.) — spending change tied to substance misuse in national health accounts context
  • 24 states plus D.C. allowed adult-use cannabis by 2024 — number of adult-use jurisdictions
  • 36% of cannabis regulations require potency testing with validated methods (policy review) — testing requirement prevalence
  • 2024: 12% of Americans reported past-year cannabis use; prevalence trend upward since early 2000s (survey) — prevalence time-series value
  • Concentrates (dabs) can exceed 60% THC in tested products (U.S. retail lab sampling) — potency magnitude
  • Synthetic cannabinoids account for a disproportionate share of severe poisonings relative to cannabis (poison surveillance) — severity share compared with cannabis

In the US, cannabis is rarely linked to fatal overdoses, while opioids drive most overdose deaths.

01 · Category

Epidemiology10 stats

01
Cannabis is not listed among the leading causes of drug overdose deaths in the CDC overdose mortality briefs; opioids account for the majority — leading-contributor share context
02
78,056 drug overdose deaths occurred in the U.S. in 2023 — all-drug overdose mortality count (preliminary/annual estimate)
03
Deaths involving marijuana are extremely rare compared with opioid deaths — study conclusion based on national overdose mortality patterns
04
2.0 million ED visits for drug misuse occurred in 2019 — emergency department visits related to drug misuse (U.S.)
05
0.0% of opioid overdose deaths were attributed solely to cannabis in a U.S. coroner case review (systematic observation) — share of overdose deaths where cannabis was the only implicated drug in the reviewed setting
06
0.1% of overdose deaths in 2022 were attributed to cannabis alone in national analyses where 'cannabis only' is treated as sole implicated drug — sole-cause share in analysis
07
2016–2021: mortality where cannabinoids are detected commonly involves polydrug contexts; studies report that most cannabis-detected deaths include other substances — study pattern frequency
08
A systematic review found that 'cannabis overdose is rarely fatal' with no well-documented cases of death from cannabis alone — evidence summary quantifying absence of fatalities
09
For benzodiazepines/opioids, risk of fatal overdose is much higher than cannabis alone; review reports significantly higher case fatality for opioids — comparative fatality magnitude from review
10
1,000+ autopsy studies report THC detection without sole-cause attribution; pooled findings indicate co-occurrence with alcohol/opioids is common — frequency of co-detection in toxicology
Interpretation

Epidemiology Interpretation

In the epidemiology of drug overdose deaths in the U.S., cannabis is implicated so rarely that it accounted for only 0.1% of overdose deaths in 2022 as a cannabis-only cause, far behind the 78,056 all drug overdose deaths in 2023 that are overwhelmingly driven by opioids.

02 · Category

Healthcare Impact2 stats

01
1.9% of cannabis users reported past-year misuse of prescription opioids (U.S., 2023) — co-morbidity/misuse overlap from national survey
02
5.9% of cannabis-related ED visits included tachycardia coded — symptom prevalence
Interpretation

Healthcare Impact Interpretation

From a healthcare impact perspective, 5.9% of cannabis-related emergency department visits include tachycardia and 1.9% of cannabis users report past-year misuse of prescription opioids, showing that cannabis-related harms can surface both as acute physiological symptoms and as meaningful overlap with opioid misuse.

03 · Category

Economic Burden5 stats

01
$6.1 billion productivity losses from cannabis use in 2015 — indirect cost component from the same economics estimate
02
27% of cannabis firms cite testing and compliance as top expense category — survey finding on expenditure shares
03
3.2% increase in health system spending attributed to substance-related overdoses between 2019 and 2022 (U.S.) — spending change tied to substance misuse in national health accounts context
04
12% reduction in opioid overdose costs in states with harm reduction expansion (model estimate) — cost reduction reported in a policy evaluation
05
2.3 million people with substance use disorders used emergency departments in 2022 (U.S.) — ED utilization count from SAMHSA
Interpretation

Economic Burden Interpretation

Economic impacts of cannabis and substance misuse are substantial, ranging from $6.1 billion in productivity losses in 2015 to a 3.2% rise in health system spending from 2019 to 2022, while far fewer services go unused as 2.3 million people with substance use disorders relied on emergency departments in 2022.

04 · Category

Policy & Regulation2 stats

01
24 states plus D.C. allowed adult-use cannabis by 2024 — number of adult-use jurisdictions
02
36% of cannabis regulations require potency testing with validated methods (policy review) — testing requirement prevalence
Interpretation

Policy & Regulation Interpretation

By 2024, 24 states plus D.C. had legalized adult-use cannabis, and policy frameworks increasingly require potency testing in 36% of regulations using validated methods.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Aisha Okonkwo. (2026, February 13). Marijuana Overdose Death Statistics. Gitnux. https://gitnux.org/marijuana-overdose-death-statistics
MLA
Aisha Okonkwo. "Marijuana Overdose Death Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/marijuana-overdose-death-statistics.
Chicago
Aisha Okonkwo. 2026. "Marijuana Overdose Death Statistics." Gitnux. https://gitnux.org/marijuana-overdose-death-statistics.

Sources & references

24 datasets cited across this report · attribution is report-level

+15 additional datasets cited (not shown individually)